PresentationGood morning, and welcome to the Agios Pharmaceuticals Investor Conference Call and Webcast. [Operator Instructions] Please be advised that this call is being recorded at Agios' request. I would now like to turn the call over to Morgan Sanford, Head of Investor Relations at Agios. Please go ahead.Morgan Sanford Thank you, operator. Good morning, everyone. Thank you for joining us to discuss top line results from the pivotal Phase III RISE UP trial of mitapivat for the treatment of sickle cell di ...